GB2392164B - Pharmaceutical formulation of fluticasone propionate - Google Patents
Pharmaceutical formulation of fluticasone propionateInfo
- Publication number
- GB2392164B GB2392164B GB0328426A GB0328426A GB2392164B GB 2392164 B GB2392164 B GB 2392164B GB 0328426 A GB0328426 A GB 0328426A GB 0328426 A GB0328426 A GB 0328426A GB 2392164 B GB2392164 B GB 2392164B
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical formulation
- fluticasone propionate
- fluticasone
- propionate
- formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Otolaryngology (AREA)
- Pulmonology (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9921396.9A GB9921396D0 (en) | 1999-09-11 | 1999-09-11 | Pharmaceutical formulation |
GB0014451A GB0014451D0 (en) | 2000-06-13 | 2000-06-13 | Pharmaceutical formulation |
GB0018654A GB0018654D0 (en) | 2000-07-28 | 2000-07-28 | Pharmaceutical formulation |
GB0320477A GB2388843B (en) | 1999-09-11 | 2000-09-11 | A metered dose inhaler containing a pharmaceutical formulation of fluticasone propionate |
Publications (3)
Publication Number | Publication Date |
---|---|
GB0328426D0 GB0328426D0 (en) | 2004-01-14 |
GB2392164A GB2392164A (en) | 2004-02-25 |
GB2392164B true GB2392164B (en) | 2004-04-07 |
Family
ID=30773574
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0328773A Expired - Fee Related GB2392915B (en) | 1999-09-11 | 2000-09-11 | Pharmaceutical formulation of fluticasone propionate |
GB0328426A Expired - Fee Related GB2392164B (en) | 1999-09-11 | 2000-09-11 | Pharmaceutical formulation of fluticasone propionate |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB0328773A Expired - Fee Related GB2392915B (en) | 1999-09-11 | 2000-09-11 | Pharmaceutical formulation of fluticasone propionate |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB2392915B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB201108039D0 (en) * | 2011-05-13 | 2011-06-29 | Mexichem Amanco Holding Sa | Compositions |
GB201117621D0 (en) | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
GB201117619D0 (en) | 2011-10-12 | 2011-11-23 | Mexichem Amanco Holding Sa | Compositions |
GB201306984D0 (en) | 2013-04-17 | 2013-05-29 | Mexichem Amanco Holding Sa | Composition |
ES2869176T3 (en) | 2015-12-04 | 2021-10-25 | Mexichem Fluor Sa De Cv | Pharmaceutical composition |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996032151A1 (en) * | 1995-04-14 | 1996-10-17 | Glaxo Wellcome Inc. | Metered dose inhaler for fluticasone propionate |
WO2000048587A1 (en) * | 1999-02-18 | 2000-08-24 | Novartis Ag | Combinations of formoterol and fluticasone propionate for asthma |
-
2000
- 2000-09-11 GB GB0328773A patent/GB2392915B/en not_active Expired - Fee Related
- 2000-09-11 GB GB0328426A patent/GB2392164B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996032151A1 (en) * | 1995-04-14 | 1996-10-17 | Glaxo Wellcome Inc. | Metered dose inhaler for fluticasone propionate |
EP1084726A2 (en) * | 1995-04-14 | 2001-03-21 | Glaxo Wellcome Inc. | Metered dose inhaler for fluticasone propionate |
WO2000048587A1 (en) * | 1999-02-18 | 2000-08-24 | Novartis Ag | Combinations of formoterol and fluticasone propionate for asthma |
Also Published As
Publication number | Publication date |
---|---|
GB0328426D0 (en) | 2004-01-14 |
GB2392164A (en) | 2004-02-25 |
GB0328773D0 (en) | 2004-01-14 |
GB2392915A (en) | 2004-03-17 |
GB2392915B (en) | 2004-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EG24044A (en) | pharmaceutical formulation of omeprazole | |
PL352282A1 (en) | Derivatives of thiazoles and pharmaceutical compositions containing these derivatives | |
PL351526A1 (en) | Pharmaceutical formulation comprising amoxycillin | |
AU2879100A (en) | Formulation and system for intra-oral delivery of pharmaceutical agents | |
HUP0201872A3 (en) | Steroid compounds and pharmaceutical compositions of the same | |
ITRM20000491A0 (en) | PHARMACEUTICAL FORMULATION OF FLUTICASONE PROPIONATE. | |
AU4328800A (en) | Pharmaceutical formulation | |
IL159576A0 (en) | Pharmaceutical formulation for the intramuscular administration of fulvestrant | |
IL154403A0 (en) | Pharmaceutical formulation of salmeterol and fluticasone propionate | |
AU2002237400A1 (en) | Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate | |
GB2392915B (en) | Pharmaceutical formulation of fluticasone propionate | |
HUP0201443A2 (en) | 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them | |
GB9909154D0 (en) | Pharmaceutical formulation | |
GB0312326D0 (en) | Pharmaceutical formulation of fluticasone propionate | |
HUP0200311A3 (en) | Use of aroyl- or arylalkanoylpyridazines for preparation of pharmaceutical compositions | |
GB9926251D0 (en) | Pharmaceutical formulation | |
HUP0203596A3 (en) | 3-methylene steroid derivative and pharmaceutical compositions containing them | |
AU1172001A (en) | Compounds and pharmaceutical compositions comprising same | |
GB9921289D0 (en) | Pharmaceutical aerosol formulation | |
GB9919840D0 (en) | Pharmaceutical formulation | |
GB9917772D0 (en) | Pharmaceutical formulation | |
GB9910636D0 (en) | Pharmaceutical formulation | |
GB9910633D0 (en) | Pharmaceutical formulation | |
GB9930878D0 (en) | Pharmaceutical formulation | |
GB9917775D0 (en) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20120911 |